Organoheterocyclic compounds
![5-Azoniaspiro[4.4]nonane Bromide 98.0+%, TCI America™](https://assets.fishersci.com/TFS-Assets/CCG/Chemical-Structures/chemical-structure-cas-16450-38-7.jpg-250.jpg)
5-Azoniaspiro[4.4]nonane Bromide 98.0+%, TCI America™
CAS: 16450-38-7 Molecular Formula: C8H16BrN Molecular Weight (g/mol): 206.127 InChI Key: PQTWYBSYKLXZME-UHFFFAOYSA-M PubChem CID: 11458396 IUPAC Name: 5-azoniaspiro[4.4]nonane;bromide SMILES: C1CC[N+]2(C1)CCCC2.[Br-]
9-(4-Biphenylyl)-3-(4-bromophenyl)carbazole 98.0+%, TCI America™
CAS: 1028648-25-0 Molecular Formula: C30H20BrN Molecular Weight (g/mol): 474.401 MDL Number: MFCD22571689 InChI Key: AZGVZMFTHCOVID-UHFFFAOYSA-N Synonym: 9-([1,1′C-Biphenyl]-4-yl)-3-(4-bromophenyl)-9H-carbazole PubChem CID: 59728582 IUPAC Name: 3-(4-bromophenyl)-9-(4-phenylphenyl)carbazole SMILES: C1=CC=C(C=C1)C2=CC=C(C=C2)N3C4=C(C=C(C=C4)C5=CC=C(C=C5)Br)C6=CC=CC=C63
Medchemexpress LLC Br-PEG7-Br | 177987-04-1 | 98.0% | 496.23 | 1 G
Br-PEG7-Br is a chemical compound with a molecular weight of 496.23 and a CAS number of 177987-04-1. It is intended for laboratory use and manufacture of substances.
- Identified uses include laboratory chemicals and manufacture of substances
- High purity of 98.0%
- Stable under recommended storage conditions
- Colorless to light yellow liquid appearance
Apexbio Technology LLC 5-Br-CTP 50ul (100 mM)
5-Br-CTP is a modified ribonucleoside triphosphate It is designed for use in the generation of RNA libraries via Systematic Evolution of Ligands by EXponential enrichment (SELEX) facilitating the selection of aptamers with enhanced stability Nucleic acids synthesized with 5-Br-CTP display improved resistance to nuclease degradation and increased thermal stability due to bromine substitution at the C-5 position of the cytosine base Based on these properties 5-Br-CTP holds research potential in aptamer selection and nucleic acid-based applications requiring enhanced structural integrity under stringent conditions
Apexbio Technology LLC 5-Br-CTP 10ul (100 mM)
5-Br-CTP is a modified ribonucleoside triphosphate It is designed for use in the generation of RNA libraries via Systematic Evolution of Ligands by EXponential enrichment (SELEX) facilitating the selection of aptamers with enhanced stability Nucleic acids synthesized with 5-Br-CTP display improved resistance to nuclease degradation and increased thermal stability due to bromine substitution at the C-5 position of the cytosine base Based on these properties 5-Br-CTP holds research potential in aptamer selection and nucleic acid-based applications requiring enhanced structural integrity under stringent conditions
Medchemexpress LLC BR-cpd7 | 98.0% | 928.82 | 1 MG
BR-cpd7 is a PROTAC degrader designed for fibroblast growth factor receptor FGFR1/2, exhibiting a DC50 of 10 nM. This compound has been observed to arrest the cell cycle and inhibit the proliferation of tumor cells that are aberrantly activated by FGFR1/2.
- Composed of a ligand for target protein FGFR-IN-12, a linker, and a ligand for E3 ligase Thalidomide-NH-CH2-COOH.
- Exhibits antitumor activity.
- Arrests cell cycle.
- Inhibits proliferation of FGFR1/2 aberrant activated tumor cells.
Medchemexpress LLC BR-cpd7 | 98.0% | 928.82 | 1 ML
BR-cpd7 is a PROTAC degrader designed to target fibroblast growth factor receptor (FGFR1/2). It has a DC50 of 10 nM and works by arresting the cell cycle and inhibiting the proliferation of FGFR1/2 aberrant activated tumor cells.
- PROTAC degrader for FGFR1/2
- DC50 of 10 nM
- Arrests cell cycle
- Inhibits proliferation of FGFR1/2 aberrant activated tumor cells